Information for Organizations Requesting Cue Rapid Molecular Tests

The Cue rapid molecular test (isothermal nucleic acid amplification test), which received emergency use authorization from the Food and Drug Administration, uses a device, test cartridge, and nasal swab to deliver COVID-19 test results in 20 minutes to an iPhone, iPad, or android device mobile application.

There are two types of Cue tests:

• Cue COVID-19 test for professional use (FDA Cue professional authorization at DHHS Letterhead: Cue COVID-19 Test [PDF])
• Cue COVID-19 test for home and over the counter (FDA Cue COVID-19 Test for Home and Over The Counter (OTC) Use - Letter of Authorization [PDF])

As noted in the emergency use authorization, the Cue test must meet the following requirements:

• Administered in a facility with a Clinical Laboratory Improvement Amendments (CLIA) certificate of compliance, certificate of accreditation, or certificate of waiver; and
• Performed by a trained staff member.

Resources from Cue:

• Visit Cue Health Monitoring System support.
• Send an email to Impact Health at cuesupport@impacthealth.com.
• Call the Cue customer support hotline at 833-283-8378, or contact customerservice@cuehealth.com.

To request a biweekly supply of the tests:

• Review the Cue Testing Information (PDF) on use and requirements for entities receiving the test.
• Submit an online form to request tests: Cue Test Order Form.

MDH has a limited supply of Cue tests. Each test order is contingent on the demand for tests and the availability of test supplies.

Questions? Email: health.test.help@state.mn.us.